Vaccination strategies for cross-protective immunity against African Horse Sickness Virus (AHSV)
<p>African Horse Sickness (AHS) is a highly lethal arboviral disease of equines. The lack of treatment makes vaccination essential. However, there are nine AHSV serotypes and AHSV immunity is serotype-specific; therefore AHSV vaccines must protect against all serotypes circulating in the field...
Autor Principal: | Manning, N |
---|---|
Outros autores: | Gilbert, S |
Formato: | Thesis |
Publicado: |
2017
|
Títulos similares
-
A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.
por: Javier Castillo-Olivares, et al.
Publicado: (2011-01-01) -
Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
por: Rachael Chiam, et al.
Publicado: (2009-06-01) -
Immune response of horses to inactivated African horse sickness vaccines
por: Marina Rodríguez, et al.
Publicado: (2020-09-01) -
Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine
por: Narongsak Chaiyabutr, et al.
Publicado: (2022-10-01) -
Genetic studies of African horse sickness virus
por: Bachanek-Bankowska, K
Publicado: (2013)